1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Sacituzumab govitecan for treating advanced non-small-cell lung cancer after platinum-based chemotherapy and a PD-1 or PD-L1 inhibitor [ID6375]

In development [GID-TA11441] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 34026-Sacituzumab-Govitecan-for-Non-Small-Cell-Lung-Cancer-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)